• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CORPORATION, ASHITAKA CAPIOX FX15 HOLLOW FIBER OXYGENATOR AF

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CORPORATION, ASHITAKA CAPIOX FX15 HOLLOW FIBER OXYGENATOR AF Back to Search Results
Catalog Number CX-XRY07702
Device Problem Coagulation in Device or Device Ingredient (1096)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 01/07/2016
Event Type  malfunction  
Manufacturer Narrative
The actual device and a photo were returned to the manufacturing facility for evaluation.A review of the photo during the actual use provided by the customer confirmed the reported complaint.The presence of white clot-like substance can be seen adhering around the fluid level graduation of 100 - 300ml.Visual inspection of the actual device found it had been marked with a large black circle and a small black-circle.In the small circle, the adhesion of white clot-like substance was found.In the large one, no such a substance was visible.There was no adhesion of white clot-like substance on the remainder of the reservoir.The white clot-like substance was fixed with glutaraldehyde solution and a specimen was sampled.Magnifying inspection of the specimen found it had a layered structure.The white clot-like substance was subjected to a ft-ir qualitative analysis and identified as protein.The white clot-like substance was subjected to a sem/edx elementary analysis and found to consist of c (carbon), o (oxygen), n (nitrogen), p (phosphorus) s (sulfur) and na (sodium).Electron microscopic inspection of the white clot-like substance found degeneration had progressed.This prevented the traces of blood corpuscles and fibrin nets from being observed.A review of the device history record of the involved product/lot # combination was conducted with no relevant findings.A search of the complaint file found no report of this nature with the involved product/lot# combination.Based on the evaluation result, the white clot-like substance is likely to be protein-origin, consisting of carbon, oxygen, nitrogen, phosphorus, sulfur and sodium.From the results of the sem/edx elementary analysis and the electron microscopic inspection, the scenario or cause of the formation of the substance cannot be determined.All available information has been placed on file in quality assurance at the manufacturing facility for appropriate tracking, trending and follow-up.
 
Event Description
The user facility reported thrombus in the capiox fx15 device.Follow up communication with the user facility confirmed the following information: the actual sample was primed with donated blood and re-circulated with it for two hours with no involvement of the patient.It was reported the customer found the adhesion of white clot-like substance on the graduated front wall of the reservoir.The composition of the prime and the order of the administration of each drug are as follows: (1) solyugen 1200ml (2) salinhes fluid solution (hydroxyethylated starch) 500m (3) mannigen 150ml (4) heparin 4,3ml (5) saline solution 1000ml (6) rcc 280ml x 2 packs (7) solyugen (8) transamine 20ml (9) cacl2 2ml; (10) the device was changed out; (11) the procedure was completed successfully; and (12) it was reported no harm to the patient.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CAPIOX FX15 HOLLOW FIBER OXYGENATOR AF
Type of Device
OXYGENATOR
Manufacturer (Section D)
TERUMO CORPORATION, ASHITAKA
150 maimaigi-cho
fujinomiya city, shizuoka 418
JA  418
Manufacturer (Section G)
TERUMO CORPORATION, ASHITAKA
reg. no. 9681834
150 maimaigi-cho
fujinomiya city, shizuoka 418
JA   418
Manufacturer Contact
jennifer suh
reg. no. 2243441
2101 cottontail ln.
somerset, NJ 08873
8002837866
MDR Report Key5401421
MDR Text Key37243881
Report Number9681834-2016-00005
Device Sequence Number1
Product Code DTZ
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K130520
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other
Type of Report Initial
Report Date 02/01/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/01/2016
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/31/2017
Device Catalogue NumberCX-XRY07702
Device Lot Number151014
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/08/2016
Is the Reporter a Health Professional? No
Date Manufacturer Received01/07/2016
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured10/14/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-